(Q43280593)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Withdrawal of fenofibrate treatment partially abrogates preventive neuroprotection in stroke via loss of vascular protection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Thavarak Ouk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Maud Laprais

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Kouach Mostafa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Sophie Gautier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Régis Bordet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

2 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

323-330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

Relationship between inward rectifier potassium current impairment and brain injury after cerebral ischemia/reperfusion

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Stroke and neurovascular protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Reduction of cerebral infarction in rats by biliverdin associated with amelioration of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Ischemic tolerance and endogenous neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Effects of statins on endothelium and signaling mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Targeting eNOS for stroke protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Targets for vascular protection after acute ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Oxidative stress: the curse that underlies cerebral vascular dysfunction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Withdrawal of statin treatment abrogates stroke protection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Cerebral preconditioning and ischaemic tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Statins and ischemic stroke severity: cytoprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Neurovascular regulation in the normal brain and in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

The neuroprotective effect of the antioxidant flavonoid derivate di-tert-butylhydroxyphenyl is parallel to the preventive effect on post-ischemic Kir2.x impairment but not to post-ischemic endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Stobadine-induced hastening of sensorimotor recovery after focal ischemia/reperfusion is associated with cerebrovascular protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Selective fluorescent imaging of superoxide in vivo using ethidium-based probes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Progress in secondary stroke prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Vascular aspects of neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC-MS/MS with electrospray ionization: assay development, validation and application to a clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

Pre-stroke use of antihypertensives, antiplatelets, or statins and early ischemic stroke outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.002

10.1016/J.VPH.2009.08.002

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19732852%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference